STAT+: Real-world psilocybin data suggest need for close monitoring

Data ReadoutpositivepsilocybinPositive

AI Analysis

Summary

Amylyx reported positive results from a pivotal trial, while real-world psilocybin data indicate a need for close monitoring. Multiple biotech industry leaders joined a pain-blocking device company board.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Amylyx reports success in pivotal trial

Importance:6/10

Sentiment:

0.60

psilocybinpivotal trialreal-world datamonitoringpain management

Related Companies

$WHEN

Read the original article

Published by STAT News on August 18, 2026 6:07 PM

Read Original